Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

3.43
Delayed Data
As of Feb 23
 -0.30 / -8.05%
Today’s Change
2.10
Today|||52-Week Range
6.41
+59.30%
Year-to-Date
No recent news for aTyr Pharma Inc.

Today’s Trading

Previous close3.73
Today’s open3.75
Day’s range3.40 - 3.80
Volume54,418
Average volume (3 months)185,744
Market cap$88.4M
Dividend yield--
Data as of 3:59pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)-185.71%
Earnings growth (this year)+17.88%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.77

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.02-0.96%
SNSSSunesis Pharmaceutic...-0.06-1.41%
GEMPGemphire Therapeutic...-0.67-6.91%
SYNSynthetic Biologics ...-0.03-3.97%
Data as of 4:00pm ET, 02/23/2017

Financials

Next reporting dateApril 5, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$0.00
Annual profit (last year)-$48.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John D. Mendlein
Vice President-
Finance
John T. Blake
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs